Two novel molecular mechanisms to account for the therapeutic efficacy of contact dermatitis against alopecia areata.
M R
MR
Namazi
D000287:Administration, Topical; D000506:Alopecia Areata / Q000188:drug therapy / Q000276:immunology*; D017449:Dermatitis, Allergic Contact / Q000276:immunology*; D015232:Dinoprostone / Q000008:administration & dosage / Q000096:biosynthesis* / Q000627:therapeutic use; D005978:Glutathione / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D005978:Glutathione; D015232:Dinoprostone